01185-6/asset/2164201a-96aa-45fd-b531-5fbac7f670fe/main.assets/gr2.jpg)
semaglutide clinical trial weight loss Oral 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 Semaglutide Approved for Type 2
Description
While the branded version (like Wegovy or Ozempic) is FDA-approved, compounded semaglutide is prepared by specialized pharmacies to meet unique patient needs, often offering flexibility in dosing and formulation
Work closely with your provider
The dosage will increase to 0.5mg for the next 2 weeks
The pricing can be found above as per the dose requirement
